Lazard Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $68.3 Billion
- Q3 2024
A detailed history of Lazard Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 16,216 shares of REGN stock, worth $11.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,216
Previous 16,450
1.42%
Holding current value
$11.1 Million
Previous $17.3 Million
1.41%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding REGN
# of Institutions
1,516Shares Held
82.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.35 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.1 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.34 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.93 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...